AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G1292-G1300, 2005. First published December 9, 2004; doi:10.1152/ajpgi.00510.2003
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/G1292    most recent
00510.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishitani, S.
Right arrow Articles by Sonaka, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishitani, S.
Right arrow Articles by Sonaka, I.

LIVER AND BILIARY TRACT

Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis

Shinobu Nishitani, Kenji Takehana, Shoji Fujitani, and Ichiro Sonaka

Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., Kawasaki-ku, Kawasaki-shi, Japan

Submitted 4 December 2003 ; accepted in final form 29 November 2004

It is well established that impaired glucose metabolism is a frequent complication in patients with hepatic cirrhosis. We previously showed that leucine, one of the branched-chain amino acids (BCAA), promotes glucose uptake under insulin-free conditions in isolated skeletal muscle from normal rats. The aim of the present study was to evaluate the effects of BCAA on glucose metabolism in a rat model of CCl4-induced cirrhosis (CCl4 rats). Oral glucose tolerance tests were performed on BCAA-treated CCl4 rats. In the CCl4 rats, treatment with leucine or isoleucine, but not valine, improved glucose tolerance significantly, with the effect of isoleucine being greater than the effect of leucine. Glucose uptake experiments using isolated soleus muscle from the CCl4 rats revealed that leucine and isoleucine, but not valine, promoted glucose uptake under insulin-free conditions. To clarify the mechanism of the blood glucose-lowering effects of BCAA, we collected soleus muscles from BCAA-treated CCl4 rats with or without a glucose load. These samples were used to determine the subcellular location of glucose transporter proteins and glycogen synthase (GS) activity. Oral administration of leucine or isoleucine without a glucose load induced GLUT4 and GLUT1 translocation to the plasma membrane. GS activity was augmented only in leucine-treated rats and was completely inhibited by rapamycin, an inhibitor of mammalian target of rapamycin. In summary, we found that leucine and isoleucine improved glucose metabolism in CCl4 rats by promoting glucose uptake in skeletal muscle. This effect occurred as a result of upregulation of GLUT4 and GLUT1 and also by mammalian target of rapamycin-dependent activation of GS in skeletal muscle. From these results, we consider that BCAA treatment may have beneficial effects on glucose metabolism in cirrhotic patients.

mammalian target of rapamycin; glycogen synthase; GLUT4; GLUT1; rat model of carbon tetrachloride-induced cirrhosis



Address for reprint requests and other correspondence: S. Nishitani and K. Takehana, 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi 210-8681, Japan (E-mail: shinobu_nishitani{at}ajinomoto.com, kenji_takehana{at}ajinomoto.com)




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Shimizu, Y. Shirakami, J. Iwasa, M. Shiraki, Y. Yasuda, K. Hata, Y. Hirose, H. Tsurumi, T. Tanaka, and H. Moriwaki
Supplementation with Branched-chain Amino Acids Inhibits Azoxymethane-induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/db Mice
Clin. Cancer Res., May 1, 2009; 15(9): 3068 - 3075.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. She, C. Van Horn, T. Reid, S. M. Hutson, R. N. Cooney, and C. J. Lynch
Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1552 - E1563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Doi, I. Yamaoka, M. Nakayama, K. Sugahara, and F. Yoshizawa
Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1683 - E1693.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz
Mild-to-Moderate Chronic Cholestatic Liver Disease Increases Leucine Oxidation in Children
J. Nutr., April 1, 2006; 136(4): 965 - 970.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.